INTACT MEDICAL Corp

INTACT MEDICAL Corp

INTACT MEDICAL Corp

Overview
Date Founded

1998

Headquarters

550 Cochituate ROAD 25 Framingham MA 01701

Type of Company

Private

Industries

Medical Products & Equipment
Hospitals & Patient Services
Holding Companies
Wholesale: Medical Supplies & Pharmaceuticals

Company Description

Intact Medical Corp. develops and distributes minimally invasive devices for the excision of breast tissue for diagnostic and therapeutic applications. It develops the next generation image-guided breast biopsy devices for the diagnosis of breast cancer. The company founded by Scott P. Huntley and Philip E. Eggers in 1998 and is headquartered in Framingham, MA.

Board of Directors

Founder at Kia Ora Foundation

Visiting Professor at University of Texas - MD Anderson Cancer Center

Founder at Rani Therapeutics LLC

Paths to INTACT MEDICAL Corp
Potential Connections via
Relationship Science
You
INTACT MEDICAL Corp
Recent Transactions
Details Hidden

INTACT MEDICAL Corp raised money in a private placement transaction

Details Hidden

INTACT MEDICAL Corp raised money in a private placement transaction

Advisors & Consultants
Advisor

Consultant at Quality Solutions Now

Investors
Details Hidden

MedVenture Associates focuses on investments in the medical technology sector, including medical devices, eHealth, healthcare services, instrumentation and medical diagnostics. The firm also invests in medical information technology, pharmaceuticals and biotechnology products. MedVenture Associates specializes in pre-seed, seed and early-stage investments. They also consider later-stage opportunities in which early investment liquidity is expected. The firm prefers to invest in early-stage companies located in the Western region of the continental US. MedVentures Associates invests in later-stage companies without regard to location. The firm seeks to serve as a sole or lead founding investor and they typically take a seat on their portfolio companies' boards of directors.

Details Hidden

Saratoga Ventures focuses on early-stage investments in the medical devices sector. The firm looks for companies with products or technologies with the potential to make a meaningful clinical impact and become a market leader. They also look for companies: (1) in which there is an unmet clinical need for their product in a large market (2) with concepts that work and are safe and efficacious (3) that have the ability to guide their innovations through the clinical and regulatory processes and get them to market (4) with innovations that have the potential to change a marketplace practice and (5) that have products with the potential for physician acceptance and adoption. Although most of their investments are in medical device companies, Saratoga Ventures make invest in ventures that overlap other life science sub-sectors.Saratoga Ventures seeks to invest in promising start-up companies that fit as acquisitions into the portfolios of major medical device companies. The firm looks for opportunities in which large, publicly-traded companies seek to outsource research and development efforts to small, entrepreneurial ventures. In addition, they are interested in opportunities in which the IPO market is a viable exit possibility. Saratoga Ventures also targets new product acquisitions of technologies which can save time, money and lives.Saratoga Ventures pursues co-investments with other prominent venture capital firms. They typically serve on the boards of directors of their portfolio companies.

Details Hidden

Calvert Capital Management, dba ABS Ventures, combines the best elements from traditional growth capital investing and secondary buyout investing to pursue special situation transactions among solid mid-stage companies with good growth potential. They have a deep understanding of the technologies they invest in, and employ active post-investment management techniques similar to an early-stage venture investor. However, ABS Ventures also has the expertise and ability to creatively structure these investments to offer new capital and liquidity to early investors, retire or restructure debt, and act as an outside lead for recapitalization.